Log in to your Inderes Free account to see all free content on this page.

ALK-Abelló

238.40 DKK

+1.53%

Less than 1K followers

ALK B

NASDAQ Copenhagen

Biotechnology & Pharmaceuticals

Health Care

Valuation

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for ALK-Abelló

P/E

Median 2019-2025

EV/S

Median 2019-2024

EV/EBIT

Median 2019-2024

Dividend yield

Median 2019-2025

P/B

Median 2019-2025

 
2019202020212022202320242025
Share price (DKK)81.75125.00171.5096.05101.20159.10228.60
Shares202.6217.7222.8222.8222.8222.8221.6
Market cap16,559.327,215.038,213.621,402.222,549.835,451.350,649.2
Enterprise value17,549.328,158.038,729.621,877.222,840.836,049.3-
EV/S5.48.19.94.84.76.5-
EV/EBITDA72.871.372.530.925.126.4-
EV/EBITneg.187.7132.646.534.333.0-
P/Eneg.1,088.6174.563.246.043.242.3
P/B5.218.6310.985.375.076.607.86
P/S5.17.89.84.74.76.48.0
Dividend yield0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %0.7 %
Equity ratio57.8 %56.7 %59.7 %63.2 %66.1 %65.2 %71.2 %
Gearing ratio39.5 %23.3 %20.4 %17.5 %17.2 %22.1 %6.5 %
Login required

This content is only available for logged in users